Evidence map›Paper›PMID 22299579›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2013

Evaluation of a dithiocarbamate derivative as an inhibitor of human glutaredoxin-1.

Satya S Sadhu, Eduardo Callegari, Yong Zhao, Xiangming Guan, Teresa Seefeldt

Open access · bronzeAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Role of glutathione metabolism in host defense againstProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Satya S SadhuDepartment of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, SD, USA.
Eduardo Callegari
Yong Zhao
Xiangming Guan
Teresa Seefeldt
South Dakota State University · USMichigan State University · USUniversity of South Dakota · US

Funding

Inhibition of glutathione reductase and ovarian cancer drug resistance reversalR15CA120062 · NCI · SOUTH DAKOTA STATE UNIVERSITY · PI GUAN, XIANGMING · 2006 to 2006
$213k
NCI NIH HHS CA120062-01NCI NIH HHS R15 CA120062
6 · The paper itself

Abstract

contextGlutaredoxins (GRX) are involved in the regulation of thiol redox state. GRX-1 is a cytosolic enzyme responsible for the catalysis of deglutathionylation of proteins. To date, very few inhibitors of GRX-1 have been reported.

objectiveThe objective of this paper is to report 2-acetylamino-3-[4-(2-acetylamino-2-carboxyethyl-sulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid (2-AAPA) as an inhibitor of human GRX-1. MATERIALS AND

methodsThe mechanism of inhibition of GRX-1 was investigated using dialysis, substrate protection, and mass spectrometry.

results2-AAPA inhibits GRX-1 in a time and concentration dependent manner. The activity did not return following dialysis indicating that inhibition is irreversible. Results of substrate protection and mass spectrometry indicate that the inhibition is occurring at the active site. The compound also produced GRX inhibition in human ovarian cancer cells. DISCUSSION: 2-AAPA is an irreversible GRX-1 inhibitor with similar or greater potency compared to previously reported inhibitors.

conclusionThe inhibition of GRX-1 by 2-AAPA could be used as a tool to study thiol redox state.

Indexed as

AcetylcysteineCell Line, TumorDialysisDose-Response Relationship, DrugDrug Evaluation, PreclinicalEnzyme InhibitorsGlutaredoxinsGlutathioneHumansThiocarbamates2-acetylamino-3-(4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl)propionic acidAcetylcysteineEnzyme InhibitorsGLRX protein, humanGlutaredoxinsGlutathioneThiocarbamates

Identifiers

PMID22299579
PMCPMC4310727
OpenAlexW2060148882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.